Tag: multiple sclerosis
May 7, 2019
TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis
TG Therapeutics (NASDAQ:TGTX) has announced presentation of long-term follow-up data of its Phase 2 open label extension trial of ubiltuximab...
February 28, 2019
An Investor’s Guide to Multiple Sclerosis
March was dubbed Multiple Scleorsis Awareness Month in 2015 by New Jersey Governor Chris Christie. Here's what investors should know.
November 25, 2018
What is In-licensing?
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
April 11, 2018
Helius Medical Begins Listing on the NASDAQ
A company getting approval to list to the NASDAQ means a more international reach for Canadian companies listing on the...
April 9, 2018
CBD is Improving Health and Driving the Cannabis Industry
CBD is improving health and driving the cannabis industry. Know more about its health benefits and opportunities for CBD-based companies.
March 14, 2018
Biogen Announces Voluntary Drug Withdrawal and Pfizer Drug Acquisition Weeks Apart, Share Price Remains Steady
March has been a busy month for Biogen with its voluntary withdrawal of Zinbryta and its acquisition of Pfizer's PF-04958242.
March 1, 2018